Shrinks In Sneakers

Tag: mental health treatment

  • Strengthening Mental Health Parity: Ensuring Equal Access to Affordable Care

    Strengthening Mental Health Parity: Ensuring Equal Access to Affordable Care

    Here are the key points from the Biden Administration’s finalized regulation:

    1. Objective: To ensure 175 million Americans with private health insurance have access to affordable mental health services.
    2. Focus: The regulation emphasizes mental health care parity, aiming for equal access and affordability between mental and physical health services.
    3. Requirements for Insurers: Health insurance providers must cover mental health services comparably to physical health services, without added hurdles.
    4. Implementation: Insurers are required to assess the adequacy of their mental health networks and take corrective action if they fall short.
    5. Broader Impact: The rule seeks to reduce out-of-pocket costs and improve access to essential mental health treatments, addressing the growing mental health crisis.
  • Heart and Mind: Answering the Call to Psychiatry

    Heart and Mind: Answering the Call to Psychiatry

    Psychiatry as a calling is a profound commitment to understanding and alleviating the complexities of the human mind. It’s more than a profession; it’s a deeply personal journey of compassion, empathy, and healing.

    At its core, psychiatry is about connecting with individuals at their most vulnerable, navigating the labyrinth of their thoughts, emotions, and behaviors to help them find light in the darkness. It’s about being a beacon of hope for those grappling with mental illness, guiding them towards resilience, recovery, and a renewed sense of purpose.

    Those who feel drawn to psychiatry often possess a unique blend of curiosity and empathy. They are captivated by the intricacies of the human psyche, driven by a genuine desire to understand the underlying causes of mental distress and suffering. They recognize that mental health is not just the absence of illness but the presence of wellness and strive to foster holistic healing in their patients.

    Psychiatrists approach their work with humility, recognizing that each individual’s journey is unique and deserving of respect and dignity. They embrace diversity in all its forms, understanding that cultural, social, and personal factors shape one’s experience of mental illness and recovery.

    Choosing psychiatry as a calling means embracing the challenges and uncertainties that come with the territory. It means bearing witness to the raw realities of human suffering while holding onto the unwavering belief in the power of resilience and transformation. It means standing alongside patients as they navigate the peaks and valleys of their mental health journey, offering support, guidance, and unwavering compassion.

    In a world where mental health stigma still persists, psychiatrists serve as advocates, educators, and champions for change. They work tirelessly to destigmatize mental illness, promote access to quality care, and foster a greater understanding of the interconnectedness of mental, emotional, and physical well-being.

    Ultimately, psychiatry as a calling is a testament to the human capacity for healing, growth, and connection. It’s a sacred bond between healer and patient, forged in empathy, nurtured by understanding, and strengthened by the shared journey towards wholeness and healing.

  • Understanding Anxiety: My Personal Experience as a Medical Student

    Understanding Anxiety: My Personal Experience as a Medical Student

    This reminds me a lot of the depression question. Patients often tell me, “Dr. Rossi, you don’t know what it’s like to be anxious.”

    I usually have a quiet chuckle to myself because anxiety is something everyone experiences. It’s a natural part of life. We all have areas where we feel competent, and others where we feel out of our depth. It’s in those areas, the places where we feel uncertain or inadequate, that anxiety can really interfere with our ability to function.

    My most challenging personal experience with anxiety happened during the infamous 4th term of medical school at St. George’s University. By this point, you’ve survived the first year and are well into the second. However, this term is notorious, and it often feels like the school uses it to weed out students—which, in my opinion, is a bit unethical. The structure of my routine completely changed. More requirements, longer lab hours, and less time to study. The familiar rhythm I had relied on to keep up was suddenly turned on its head.

    Throughout that term, I was constantly on edge, overwhelmed by the pressure that all my hard work could slip away at any moment. I still vividly remember the first time I experienced a panic attack. It was early morning; I woke up drenched in sweat, my heart racing, and I couldn’t catch my breath. I was scared enough to go to the university clinic, and that’s when I found out it was a panic attack.

    That experience taught me firsthand what anxiety truly feels like. It’s not just a fleeting worry—it can become physical, paralyzing, and all-consuming. When I talk to patients about anxiety, it’s from a place of understanding. Anxiety doesn’t discriminate, and it certainly doesn’t mean we’re incapable—just human.

  • Ketamine: A Temporary Fix, Not a Cure for Depression

    Ketamine: A Temporary Fix, Not a Cure for Depression

    It’s crucial to understand that ketamine is not a cure for depression. Many individuals experience a relapse, often within 2 to 4 weeks after finishing the initial treatment. If you’re expecting ketamine to fully resolve your depression, this could lead to disappointment and potentially harmful consequences.

  • Doctor’s Near-Death Experience: The Truth Behind Antidepressant Withdrawal – Fact or Fiction

    Doctor’s Near-Death Experience: The Truth Behind Antidepressant Withdrawal – Fact or Fiction

    These sensational headlines about near-death experiences coming off antidepressants are becoming far too common. While we must be cautious with prescribing, it’s equally important not to dissuade people from trying medications that could help them.

    Yes, some patients experience withdrawal symptoms if medications are stopped abruptly without proper tapering. But many patients do not, and I’ve seen countless cases where people discontinue their antidepressants without any issues. Some may require prolonged tapers, while others can taper off much faster than alarmist articles would suggest.

    It’s crucial to remember that while discontinuation can be uncomfortable, it’s rarely life-threatening. We do need to be mindful of how long we prescribe these medications, given they manage symptoms but don’t modify the underlying disease, and the long-term benefits are still debated.

    Guidelines for deprescribing are helpful, but dramatic headlines about “nearly dying” when coming off these medications are not only inaccurate but harmful to those who could benefit from treatment. Let’s promote balanced, evidence-based discussion on this topic, focusing on proper discontinuation without sensationalizing the risks.

    Link to article: https://www.theguardian.com/australia-news/article/2024/jul/31/australian-doctor-mark-horowitz-who-almost-died-writes-landmark-guidance-on-how-to-safely-stop-using-antidepressants

  • Surge in Antidepressant Overdoses Alarms Health Experts Across the U.S

    Surge in Antidepressant Overdoses Alarms Health Experts Across the U.S

    Rising Antidepressant Overdoses: A Growing Concern in the U.S.

    Recent data reveals that antidepressant overdoses in the U.S. have been steadily increasing from 1999 through 2022. According to a CDC report released last month, there were 5,863 overdose deaths attributed to antidepressants in 2022—numbers comparable to heroin-related fatalities, which claimed 5,871 lives. While these figures represent a small fraction of the over 100,000 overdose deaths that year—most of which involved fentanyl—they signal a troubling trend that demands attention.

    Potential Causes for the Rise in Antidepressant Overdoses

    Understanding the root causes of this increase is challenging, given the complexity of overdose data and the lack of detail on the exact substances involved. However, there are several factors worth considering.

    First, many individuals with opioid use disorder (OUD) also suffer from co-occurring mental health conditions like depression and bipolar disorder. These patients are often prescribed antidepressants, sometimes too liberally, in my experience working in community mental health. When opioids are mixed with antidepressants, opioids are often the primary cause of death in overdoses. Yet, I’ve also encountered numerous patients who have attempted suicide using antidepressants alone.

    Newer antidepressants are generally safer in overdose compared to older drugs, such as monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs). While these older medications tend to be more effective, they come with significantly higher risks in overdose situations. This is something I frequently emphasize to residents: older drugs are more dangerous, but the newer ones, though safer, can still have serious consequences.

    Chronic pain patients, who are often prescribed opioids, are another vulnerable group. Their risk of suicide is heightened by the constant pain they endure, and many of these individuals are also prescribed antidepressants like duloxetine, which is indicated for pain management, or more dangerous TCAs such as amitriptyline and nortriptyline. Additionally, gabapentin—another drug commonly prescribed to these patients—has been known to increase the risk of death when taken with opioids.

    Overprescription of Antidepressants: A Contributing Factor?

    There has also been a sharp rise in antidepressant prescriptions across the U.S., which I believe warrants scrutiny. Antidepressants are, at best, symptom management tools, with a modest effect size of 0.33 in many studies. Given these limited benefits, we should be more judicious about who we prescribe these medications to and for how long.

    Withdrawal symptoms from long-term—and sometimes even short-term—use of antidepressants can be severe, increasing the risk of suicide. I’ve personally seen this with a family member who experienced debilitating headaches and vertigo after stopping sertraline. She was unable to work or function for nearly two weeks, highlighting how challenging withdrawal can be for some patients.

    Balancing Risks and Benefits in Mental Health Treatment

    Any population for whom antidepressants are considered a treatment option is inherently at high risk for suicide. That said, there are many confounding factors in the overdose data, and mainstream mental health reporting often glosses over the nuances of psychiatric research and treatment. When prescribing medications, it’s crucial to weigh not only the pros and cons of the drugs themselves but also to tailor treatment to each individual’s unique needs.

    I continue to prescribe antidepressants to patients whom I’ve carefully evaluated and believe will benefit, even if only in the short term. However, I am transparent with them: antidepressants are unlikely to resolve deeper psychological conflicts or “problems of living.” Mental health is rarely black and white, and much of this uncertainty stems from our incomplete understanding of the brain.

    In short, we need to acknowledge the complexity behind the rise in antidepressant overdoses and respond with a more nuanced, patient-centered approach to prescribing these medications.

    Link to the article:

    https://www.theguardian.com/science/article/2024/sep/03/antidepressants-overdose-deaths-increasing

  • Enlarged Brain Networks: A Hidden Signature of Depression from Childhood Onward

    Enlarged Brain Networks: A Hidden Signature of Depression from Childhood Onward

    The article “Frontostriatal salience network expansion in individuals in depression” highlights new research findings showing that individuals with depression have enlarged brain networks associated with emotional processing. The study, conducted on both children and adults, reveals that specific brain regions linked to depression display structural differences, with these regions being larger than those in non-depressed individuals.

    The researchers particularly focused on the amygdala and hippocampus, which are key to emotions and memory. This enlargement appears to start in childhood, suggesting early neurodevelopmental factors might contribute to the onset of depression later in life. The findings could lead to better understanding of depression’s biological roots and improve early detection and treatment strategies.

    Link to the article: https://www.nature.com/articles/s41586-024-07805-2

  • Suicide Prevention: A Personal Commitment to Hope and Healing

    Suicide Prevention: A Personal Commitment to Hope and Healing

    I thought I would share one of my favorite songs (Eminem Beautiful) as I reflect on what suicide prevention means to me. 

    link to song if you haven’t heard it: https://www.youtube.com/watch?v=SBb11rmHLIY

    This past year has been one of the most challenging times of my life. I watched my 20-year relationship fall apart, missed crucial professional opportunities, and questioned nearly every decision I’ve ever made. To say I was struggling would be an understatement. What stung even more was the silence from people I thought were my friends—they never reached out, never asked how I was doing. It left me feeling hollow and alone.

    But instead of letting that break me, I took this as a chance to reflect on who my real friends are, and I focused on building myself—mind and body—stronger than ever. I refused to let this hardship define or defeat me.

    When patients tell me they’re at their breaking point, I understand that feeling. But I also know they’ve only tapped into a fraction of their strength. There’s so much more to give, more life to live. During dark times, it’s easy to feel unheard and invisible, but I promise you—I’m here, I’m listening, and we can get through anything.

    If you or someone you love is in a dark place, please reach out for help. You are not alone, and your story is far from over. Don’t ever let anyone tell you that you’re not beautiful—because you are.

  • Inpatient Psychiatry: Sanctuary for Healing or Profit-Driven Trap?

    Inpatient Psychiatry: Sanctuary for Healing or Profit-Driven Trap?

    The New York Times typically does a good job of investigating and reporting on mental health topics, but in this case, it seems they missed the mark, especially in representing inpatient psychiatry. Inpatient psychiatry is a challenging environment for both patients and physicians like myself. We never want to keep anyone in the hospital who doesn’t need to be there. In fact, when patients accuse me of holding them for financial gain, I tell them that I’m paid the same regardless of the number of cases I manage, and my life is easier with fewer patients. No physician working in inpatient care would ever keep someone confined without a legitimate safety concern for the patient or the community. While no one defends poor practices, and Arcadia may indeed have its issues, the broader implications of articles like this one deserve closer scrutiny. The article lacks detail, avoids expert input from professionals in the field, and fails to account for the fact that dangerousness might emerge during hospitalization, potentially converting a voluntary patient to involuntary status or necessitating a more cautious discharge approach that could save lives.

    Here’s the reality: people are admitted to inpatient psychiatric units for a variety of reasons. We can talk all day about the broken U.S. healthcare system and the lack of access to quality outpatient psychiatric care, but fundamentally, there are two main reasons someone ends up on an inpatient unit. First, they are a danger to themselves, and without close monitoring and treatment, they are at high risk of suicide. Second, they pose a danger to others, and without inpatient care, serious harm could come to someone else. We see plenty of cases that meet these clear criteria, and I believe that without our services, many of these individuals would either be dead or in jail. However, there are also other reasons why patients seek inpatient care, and the article’s example of a woman with bipolar disorder needing a medication adjustment is worth exploring.

    Why not see an outpatient psychiatrist for medication management? Why seek inpatient care from a doctor who doesn’t know your case? This situation can be dissected further. Suppose this patient, who doesn’t pose a threat to themselves or others, voluntarily enters an inpatient unit for treatment. Medication changes are made, lithium is increased, and as the treating physician, you would need at least 3-5 days for observation and lab work to monitor the effects. Given that this patient could have pursued outpatient treatment, it becomes your responsibility as the inpatient doctor to ensure proper monitoring and follow-up. But let’s say, after admission, you learn that the patient had been suicidal the week prior and had a plan to overdose. Now, there’s new information indicating a greater level of risk. If, after 24 hours, the patient suddenly wants to leave, as the physician, you must consider this new information. You ask to speak to the patient’s family to gather more context, but the patient refuses and demands discharge. In my state, the patient would file a formal 48-hour notice, which allows me 48 hours to assess if they pose an imminent danger. If so, a two-physician commitment process can be initiated.

    The point is that treating physicians must weigh numerous safety concerns—such as unfinished medication adjustments, potential emerging risks, and patients’ misunderstanding of the inpatient process. Mental health treatment often takes weeks to months to see full results, and if patients feel significantly better after just a few days, it’s either due to electroconvulsive therapy (ECT) or the placebo effect of being in a hospital setting. I believe it’s crucial for people to understand the role of inpatient psychiatric facilities, and I make it a point to educate my patients about why hospitalization is necessary and what they can expect. Many arrive with false assumptions about what can be accomplished in an inpatient setting.

    Link to New York Times Article: https://www.nytimes.com/2024/09/01/business/acadia-psychiatric-patients-trapped.html

  • Mastering the Mind: Strategies for Tackling Anxious Depression

    When treating anxious depression, SSRIs and SNRIs may not always provide sufficient relief. In such cases, I consider adding medications like quetiapine, which has a significant effect size for generalized anxiety disorder (GAD) and is FDA-approved as an augmentation strategy for depression at doses of 150–300 mg. However, due to its side effect profile, it’s advisable to limit the duration of quetiapine use when possible.